📌 Key Takeaways
- Topic: Aerosil R972: Specifications, Hydrophobic Properties and Equivalent Grades
- Keywords: silica reinforcing filler
- Published: 2026-11-20 00:38:52
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Nano Silica? Particle Size, Properties, Production and Applications
- Quartz Powder for Ceramics: Functions, Grades and Particle Size Selection
- Vallet‐Regí, M., Balas, F. & Arcos, D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. 46, 7548-7558 (2007). Article Google Scholar
- Silica for Battery Separator: Benefits for Lithium-Ion and Lead-Acid Batteries
- U.S. Silica: Company Overview, Products and Markets Served
- He, C., Yu, L., Yao, H., Chen, Y. & Hao, Y. Combinatorial photothermal 3D‐printing scaffold and checkpoint blockade inhibits growth/metastasis of breast cancer to bone and accelerates osteogenesis. Adv. Funct. Mater. 31, 2006214 (2021). Piece CAS Google Scholar
- 325 Mesh Silica: Particle Size, Specifications and Common Applications
- Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101-124 (2021). Post CAS PubMed Google Scholar
Matting Agent for Coatings: Types, Selection Guide and Performance Comparison
What is silica (SiO₂)?
precipitated silica market
What is the difference between fumed silica and precipitated silica?
high purity quartz supplier
What drives silica raw material prices?
silica filler for plastics MSNs-based scaffolds can enhance the cell proliferation, migration, adhesion and differentiation in bone tissue engineering. Many studies have systematically investigated and revealed the function of MSNs-based scaffolds in the regulation of cellular functions. 483, 484, 485, 486 Bone defects-involved regenerative mend is challenging to obtain a desired outcome due to the delay of early vascularization and poor osteogenic activity of bone implants. In this regard, researchers have designed a polycaprolactone network containing vascular-like structure, and introduced a nanofibrous gelatin-silica scaffold into it. Dimethyloxalylglycine (DMOG) and peptide-1 (BFP) were then loaded into MSNs, and the differential spatial distribution and sequential release of DMOG and BFP allowed the bioactive scaffold to promote angiogenesis by stimulating the migration of human umbilical vein endothelial cells (HUVECs), the tube formation and the expression of angiogenesis-related genes/proteins (HIF-1α, e-NOS, KDR and VEGF), as well as enhance osteogenesis by upregulating the expression of bone marrow-derived mesenchymal stem cells (BMSCs)-related osteogenic genes (Runx2, Col I, OPN and OCN) and promoting mineral matrix formation. 487 Apart from, Mora-Raimundo et al. reported MSNs as a nanocarrier to deliver SOST small interfering RNA (siRNA) and osteostatin, and the as-designed system could be used for osteoporosis remission via enhancing the bone microarchitecture. 379 Wang et al. designed a biomimetic silica-collagen scaffold via a robust biosilicification tactic, and the silica-collagen scaffold could mimic the distinctive microenvironment of bone extracellular matrix (ECM), resulting in the improvement of mesenchymal stem cell (MSC) recruitment and bone repair. 488 These MSNs-based scaffolds have excellent potential for clinical translation in the treatment of bone defects.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.